These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

262 related items for PubMed ID: 6427436

  • 21. [Somatomedins and growth disorders].
    Job JC, Donnadieu M, Schimpff RM.
    Rev Prat; 1979 Feb 21; 29(11):925-6, 929-30, 933-4. PubMed ID: 432489
    [No Abstract] [Full Text] [Related]

  • 22. [Therapeutic indications in growth retardation].
    Job JC.
    Presse Med; 1991 Feb 02; 20(4):149-51. PubMed ID: 1825869
    [No Abstract] [Full Text] [Related]

  • 23. Stepwise evaluation of the short child. With comments on the status of growth hormone therapy.
    Stelling MW.
    Postgrad Med; 1986 May 01; 79(6):185-7, 190-2. PubMed ID: 3085075
    [Abstract] [Full Text] [Related]

  • 24. [Growth hormone treatment of children with short stature secondary to intrauterine growth retardation].
    Chaussain JL, Carel JC.
    Arch Pediatr; 1998 May 01; 5 Suppl 4():345S-347S. PubMed ID: 9853081
    [Abstract] [Full Text] [Related]

  • 25. Human growth hormone: recent advances and current status.
    Bourgeois MJ.
    Indian J Pediatr; 1986 May 01; 53(2):133-9. PubMed ID: 3744452
    [No Abstract] [Full Text] [Related]

  • 26. Growth hormone treatment and the short child: to treat or not to treat?
    Bercu BB.
    J Pediatr; 1987 Jun 01; 110(6):991-5. PubMed ID: 3295165
    [No Abstract] [Full Text] [Related]

  • 27. Dose effects of growth hormone during puberty.
    Saenger P.
    Horm Res; 2003 Jun 01; 60(Suppl 1):52-7. PubMed ID: 12955018
    [Abstract] [Full Text] [Related]

  • 28. The influence of secular trend for height on ascertainment and eligibility for growth hormone treatment.
    Hughes IP, Choong CS, Cotterill A, Harris M, Davies PS, Australasian Paediatric Endocrine Group.
    Clin Endocrinol (Oxf); 2010 Dec 01; 73(6):760-8. PubMed ID: 20846295
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Plasma somatomedin activity and urinary hydroxyproline excretion during administration of human growth hormone in children with short stature. Long-term effects and relation with short-term changes.
    Wit JM, Van den Brande JL.
    Horm Res; 1984 Dec 01; 19(4):216-23. PubMed ID: 6745842
    [Abstract] [Full Text] [Related]

  • 31. Human growth hormone treatment of children with growth failure and normal growth hormone levels by immunoassay: lack of correlation with somatomedin generation.
    Plotnick LP, Van Meter QL, Kowarski AA.
    Pediatrics; 1983 Mar 01; 71(3):324-7. PubMed ID: 6681897
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. The somatomedins.
    Hintz RL.
    Adv Pediatr; 1981 Mar 01; 28():293-317. PubMed ID: 7041561
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. [Somatomedins and their significance in pediatrics].
    Vetter U, Teller WM.
    Klin Padiatr; 1985 Mar 01; 197(5):378-85. PubMed ID: 3906254
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Evaluation of growth disorders in children.
    Cuttler L.
    Pediatrician; 1987 Mar 01; 14(3):109-20. PubMed ID: 3134649
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 14.